Literature DB >> 26628960

Expression of Jagged1 predicts postoperative clinical outcome of patients with gastric cancer.

Hao Liu1, Heng Zhang1, Zhenbin Shen1, Xuefei Wang1, Zhenglin Wang1, Jiejie Xu2, Yihong Sun1.   

Abstract

BACKGROUND: Clinical significance of Notch1 activation in gastric cancer has been elucidated in our previous study, but the role of its ligands remains obscure. This study aims to evaluate the prognostic value of Jagged1 expression in patients with gastric cancer.
METHODS: We examined Jagged1 expression in tumor and nontumor tissues in retrospectively enrolled 302 patients with gastric cancer undergoing gastrectomy at Zhongshan Hospital of Fudan University in 2008 by immunohistochemical staining. The Kaplan-Meier method and Cox regression models were used to evaluate the prognostic value of Jagged1 expression and its association with clinicopathological features. We created a predictive nomogram by integrating Jagged1 expression with the TNM staging system for overall survival of gastric cancer patients.
RESULTS: Jagged1 expression in gastric cancer was decreased compared with that in nontumor tissues. Low expression of Jagged1 in tumor and nontumor both predicted a dismal outcome. The Jagged1 risk derived from Jagged1 expression in tumor/nontumor tissue gave a further discrimination for the prognosis of gastric cancer patients. By Cox multivariate analysis, the Jagged1 risk was defined as an independent prognostic factor. The generated nomogram performed well in predicting the 3- and 5-year overall survival of gastric cancer patients.
CONCLUSION: Jagged1 is a potential prognostic biomarker for overall survival, which could be integrated with TNM stage to give a better risk stratification for gastric cancer patients.

Entities:  

Keywords:  Gastric cancer; Jagged1; biomarker; nomogram; overall survival; prognosis

Year:  2015        PMID: 26628960      PMCID: PMC4658849     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  24 in total

1.  Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia.

Authors:  Andrew P Weng; Adolfo A Ferrando; Woojoong Lee; John P Morris; Lewis B Silverman; Cheryll Sanchez-Irizarry; Stephen C Blacklow; A Thomas Look; Jon C Aster
Journal:  Science       Date:  2004-10-08       Impact factor: 47.728

2.  Notch4 intracellular domain binding to Smad3 and inhibition of the TGF-beta signaling.

Authors:  Youping Sun; William Lowther; Katsuaki Kato; Caterina Bianco; Nicholas Kenney; Luigi Strizzi; Dina Raafat; Morihisa Hirota; Nadia I Khan; Sharon Bargo; Brenda Jones; David Salomon; Robert Callahan
Journal:  Oncogene       Date:  2005-08-11       Impact factor: 9.867

3.  High-level JAG1 mRNA and protein predict poor outcome in breast cancer.

Authors:  Brendan C Dickson; Anna Marie Mulligan; Hui Zhang; Gina Lockwood; Frances P O'Malley; Sean E Egan; Michael Reedijk
Journal:  Mod Pathol       Date:  2007-06       Impact factor: 7.842

4.  The intracellular domain of Jagged-1 interacts with Notch1 intracellular domain and promotes its degradation through Fbw7 E3 ligase.

Authors:  Mi-Yeon Kim; Jane Jung; Jung-Soon Mo; Eun-Jung Ann; Ji-Seon Ahn; Ji-Hye Yoon; Hee-Sae Park
Journal:  Exp Cell Res       Date:  2011-07-29       Impact factor: 3.905

5.  X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization.

Authors:  Robert L Camp; Marisa Dolled-Filhart; David L Rimm
Journal:  Clin Cancer Res       Date:  2004-11-01       Impact factor: 12.531

Review 6.  Notch signalling in solid tumours: a little bit of everything but not all the time.

Authors:  Prathibha Ranganathan; Kelly L Weaver; Anthony J Capobianco
Journal:  Nat Rev Cancer       Date:  2011-04-14       Impact factor: 60.716

7.  High Jagged1 expression predicts poor outcome in clear cell renal cell carcinoma.

Authors:  Kerong Wu; Le Xu; Li Zhang; Zongming Lin; Jun Hou
Journal:  Jpn J Clin Oncol       Date:  2010-11-08       Impact factor: 3.019

8.  Notch3 and Jagged2 contribute to gastric cancer development and to glandular differentiation associated with MUC2 and MUC5AC expression.

Authors:  Haeyoun Kang; Hee-Jung An; Ji-Ye Song; Tae-Heon Kim; Jin-Hyung Heo; Dae-Ho Ahn; Gwangil Kim
Journal:  Histopathology       Date:  2012-10       Impact factor: 5.087

9.  Jagged1 is the pathological link between Wnt and Notch pathways in colorectal cancer.

Authors:  Verónica Rodilla; Alberto Villanueva; Antonia Obrador-Hevia; Alex Robert-Moreno; Vanessa Fernández-Majada; Andrea Grilli; Nuria López-Bigas; Nicolás Bellora; M Mar Albà; Ferran Torres; Mireia Duñach; Xavier Sanjuan; Sara Gonzalez; Thomas Gridley; Gabriel Capella; Anna Bigas; Lluís Espinosa
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-26       Impact factor: 11.205

10.  Activation of the Notch1/STAT3/Twist signaling axis promotes gastric cancer progression.

Authors:  Kai-Wen Hsu; Rong-Hong Hsieh; Kuo-Hung Huang; Anna Fen-Yau Li; Chin-Wen Chi; Tzu-Yin Wang; Min-Jen Tseng; Kou-Juey Wu; Tien-Shun Yeh
Journal:  Carcinogenesis       Date:  2012-05-10       Impact factor: 4.944

View more
  3 in total

1.  Downregulation of Notch Signaling in Kras-Induced Gastric Metaplasia.

Authors:  Wen-Cheng Chung; Yunyun Zhou; Azeddine Atfi; Keli Xu
Journal:  Neoplasia       Date:  2019-07-02       Impact factor: 5.715

2.  A Comprehensive Bioinformatic Analysis of NOTCH Pathway Involvement in Stomach Adenocarcinoma.

Authors:  Dongyun Xue; Dong Li; Cong Dou; Junshan Li
Journal:  Dis Markers       Date:  2021-12-08       Impact factor: 3.434

3.  Identification of genes associated with gastric cancer survival and construction of a nomogram to improve risk stratification for patients with gastric cancer.

Authors:  Yongfeng Ding; Yanyan Chen; Mengjie Wu; Linrong Li; Yingying Huang; Haiyong Wang; Haohao Wang; Xiongfei Yu; Nong Xu; Lisong Teng
Journal:  Oncol Lett       Date:  2020-04-15       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.